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Introduction: In 2016, cardiovascular diseases (CVDs) led to 17.9 million deaths world-
wide, representing 31% of all global deaths. CVDs are the leading cause of mortality 
worldwide and significant barriers to achieving the sustainable development goals. Modern 
medicines have been significant in improving health outcomes. However, non-adherence to 
medication is one of the reasons behind adverse health-related outcomes among patients 
suffering from atherosclerotic cardiovascular disease in low- and middle-income countries.
Patients and Methods: This qualitative study was conducted at two tertiary care hospitals 
in India and Ghana. A total of 35 in-depth interviews were conducted with atherosclerosis 
cardiovascular disease (ASCVD) patients. The data were analysed thematically using the 
Capability Opportunity and Motivation (COM-B) framework.
Findings: The findings were summarised under three important broad themes of the COM-B 
framework: capability, opportunity and behaviour. Under capability, comprehension of dis-
ease, medication schedule, and unplanned travel affected adherence among patients. Cost of 
medication, insurance and access were the critical factors under opportunity, which nega-
tively influenced medication adherence. Mood, beliefs about treatment and outcome expecta-
tions under motivation led to non-adherence among patients. Apart from these factors, some 
important health system factors such as health care experience and trust in the facilities and 
reliance on alternative medication also affected adherence in both countries.
Conclusion: This study has highlighted that the health system factors have dominantly 
influenced adherence to medication in India and Ghana. In India, we found participants to be 
satisfied with their health care provided at the government hospitals. However, limited time 
for consultation, lack of well-stocked pharmacy and unclear prescription negatively influ-
enced adherence among participants in India and Ghana. The study emphasises that the 
health system needs to be strengthened, and the patients’ belief system needs to be explored 
to address the issue of medication adherence in LMICs.
Keywords: non-communicable diseases, atherosclerotic cardiovascular disease, public 
health, qualitative research
Introduction
In 2016, Cardiovascular Diseases (CVDs) led to 17.9 million deaths worldwide, 
which represented 31% of all global deaths.1 The analysis of the Global Burden of 
Disease study 2016, reveals that CVDs represents 24% of the Non-communicable 
Diseases (NCDs) related DALYs.2 Studies show that in 2015 alone, low and 
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middle-income countries (LMICs) accounted for more 
than five million deaths due to CVDs (WHO, 2017). 
LMICs bear the largest burden of CVDs, and most have 
limited resources to curtail the increasing burden of 
CVDs.3
Various population-based studies have found an asso-
ciation between socio-demographic characteristics such as 
increasing age, gender and lower education, and the 
increasing burden of CVDs.4 Other factors contributing 
to the rise in CVDs are metabolic (high blood pressure, 
high blood glucose, dyslipidemias, obesity) and beha-
vioural risk factors (tobacco use, unhealthy diet, physical 
inactivity).5
Modern medicines have played a significant role in 
improving health outcomes. However, non-adherence to 
medication is one of the reasons behind adverse health- 
related outcomes among atherosclerotic cardiovascular 
disease (ASCVD) patients.6,7 Adherence to the medication 
has been defined as “active, voluntary, and collaborative 
involvement of the patient in a mutually acceptable course 
of behaviour to produce a therapeutic result”.8 Therefore, 
non-adherence to medication is a behaviour choice which 
is determined by psychosocial, economic, and health sys-
tem factors.
One of the effective ways of averting CVD mortality is 
secondary prevention, which includes strategies that effec-
tively reduce the probability of recurrence of 
a cardiovascular event in patients with known athero-
sclerotic CVDs.9 Risk factor modification, counselling, 
and medication adherence can help reduce CVD-related 
morbidity and mortality.10
The study took place in Ghana and India. According to 
WHO estimates, in Ghana, the probability of dying from 
NCDs, including CVDs, within the age group of 30 to 70 
years is 20.8%.11 Many Ghanaians with NCDs such as 
high blood pressure are unaware of their condition, and of 
those who are aware and on treatment, less than 5% have 
controlled blood pressure.12,13 The referral facility tends to 
receive these cases at a late stage of the illness, and this 
further burdens the health system of the country. Similarly, 
CVDs are the leading cause of mortality in India.14 As the 
largest proportion of the population, lower socio-economic 
groups contribute most to the burden of CVDs risk factors 
in India.15 A study hypothesized that a combination of four 
drugs (aspirin, a β-blocker, a statin, and an angiotensin- 
converting enzyme [ACE] inhibitor) could reduce CVD 
events by 75% in those with vascular disease.16 However, 
the PURE study registered low usage of the combination 
of these four drugs in LMICs.17
The focus of this paper is to understand existing local 
barriers to medication use, including socio-psychological, 
economic, and health system barriers in two LMICs-India 
and Ghana. This paper is part of a larger study (Txt2Heart) 
which aimed first to understand the barriers for using 
medication for ASCVD and then, using behavioural 
change techniques, develop SMS messages to improve 
medication adherence in these settings.
Methods
The Study Setting
In Ghana, participants recruited for this study were 
patients diagnosed with CVDs receiving treatment from 
a tertiary health facility. The hospital is situated in the La 
Dade Kotopon District of Greater Accra Region. The dis-
trict is much urbanised and serves as both a domicile and 
commercial setting for its population. The Hospital is 
a referral health facility within the country and provides 
general healthcare services for patients in and out of the 
national capital, Accra. It offers services for patients on the 
country’s National Health Insurance Scheme (NHIS) as 
well as for private health insurance and out of pocket 
patients.
In India, participants were recruited from a tertiary care 
hospital in New Delhi, India. The hospital provides health 
care to CVD and other patients from all across India.
Sampling
ASCVD patients from the tertiary care Hospital in Ghana 
were identified retrospectively through a desk review of 
patients’ folders, and prospectively in India by one on one 
interaction with patients visiting the outpatient department 
(OPD) at the hospital, in New Delhi, on their scheduled 
check-up.
In-depth interviews (IDIs) and focus group discussions 
(FGDs) were conducted with 35 (16 from India and 19 
from Ghana) purposively selected participants using 
a topic guide. Participants were included if they were 
over 18 years old with six months of history of established 
ASCVD (See Table 1).
Trained research staff from the Centre for Chronic 
Disease Control (CCDC), India, and the School of Public 
Health, University of Ghana collected the data. The IDIs 
and FGDs were conducted in the local language. Hindi 
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was the preferred language of the participants in India, and 
in Ghana, interviews were conducted in Twi and Ga.
Ethics approval for the study was obtained from the 
ethics committee of CCDC (reference: IRB00006330) and 
the participating hospital (reference: IEC-486/07.10.2016, 
RP 5/2016, RP 34/2017), in India. In Ghana, ethical 
approval was obtained from the Ethical Review 
Committee of the Ghana Health Service (reference: 
GHS/RDD/ERC/Admin/App/16/189; GHS-ERC 06-09- 
2016). In the UK ethical approval was granted by the 
London School of Hygiene & Tropical Medicine 
Research Ethics Committee (LSHTM Ethics Ref: 12046)
As the fundamental ethical principle for this study, we 
ensured the participants’ anonymity throughout the data 
collection and analysis process. All participants were pro-
vided with an information sheet and consent form in their 
local language. Researchers at both sites read the informa-
tion sheet and consent line by line to each participant and 
asked if they had any queries. Written consent was 
obtained from participants for recording interviews.
The data were collected between May and 
October 2017. The a priori themes that guided the inter-
views included disease perception, taking medicines, per-
ception of the health systems, support network in the 
treatment, use and appropriation of technology. W asked 
participants questions such as: What has been your experi-
ence with cardiovascular disease?; Currently, are you 
taking medications for your disease?; and Do you take 
any medicines? How do you feel about that? Is it some-
times difficult to take them? Why? Do you feel these 
medicines help you? Or harm you?
Analysis
We explored data around six major themes, including 
disease perception/description of disease event, adherence 
to medication, and health systems barriers and facilitators. 
We usedCOM-B framework to analyse the data, which 
proposes that Capability, Opportunity and Motivation 
cause change in Behaviour (COM-B)18 to address medica-
tion adherence. The context-specific emergent themes 
were added to expand the existing COM-B framework.
In contrast to previous unidimensional frameworks, 
COM-B is a comprehensive and solution-oriented frame-
work that applies to various health-related behaviours.19 
The COM-B framework helps in understanding specific 
behaviours and their causes. In this study, COM-B has 
been used to understand the health-related behaviours of 
patients in two different settings: India and Ghana.
The COM-B framework has three crucial components: 
capability, opportunity and motivation. The capability com-
ponent has two sub-components: psychological and physical. 
Psychological capability deals with the cognitive ability of 
patients. Physical capability focuses on patients’ ability to 
modify their lifestyle. The opportunity component of the 
framework also has two sub-components: physical and 
social. The physical opportunity comprises of cost of medi-
cine, packaging, physical appearance, access to medicines 
and health services, regime complexity, communication 
between doctor and patients and the social support provided 
to patients. Social opportunity includes the stigma attached to 
the disease and the cultural beliefs that affect adherence. The 
motivation component revolves around reflective and auto-
matic factors affecting a patients’ motivation. The reflective 
factor includes patients’ perception of illness, belief about the 
treatment and the outcome, whereas automatic motivation 
focuses on stimuli, mood or state of mind.
All the recorded interviews were transcribed and then 
translated into English by trained transcribers in India and 
Ghana. In India, the researcher who conducted the IDIs 
coded all the transcripts using QSR-NVivo 10. A team of 
two researchers coded transcripts in Ghana using QSR 
NVivo 11. A priori codes were derived from the COM-B 
framework, and the transcripts were coded using the inter-
pretative approach, and deductive logic. This framework 
was adopted to guide the inquiry at the initial stage, and 




Male participant 10 9
Female participant 06 10
Mean age 51.37 61.74
known Ischaemic Heart Disease (IHD) 8 2
Ischemic stroke 4 13
Myocardial infarction 3 1
Coronary Artery Bypass Graft (CABG) 1 0
Cardiomyopathy 0 1
Acute Coronary Syndrome (ACS) 0 1
Multivalvular Heart Disease 0 1
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finally, a broader application of the themes and the con-
cepts was developed. Thematic saturation was reached 
when no more themes were emerging from the data.
The evidence generated from the data was reconciled in 
the proposed framework. There were various linear stages 
followed in the analysis during and after the fieldwork. The 
researcher read and re-read the transcripts and field notes 
during and after the data collection to become familiar with 
the data. It also helped in identifying themes, following 
which labels were assigned to the data. Later, summaries 
of data under various labels were prepared, and initial 
themes were refined. Summary for each code and shared 
within the team, which included researchers from India, 
Ghana and the UK to identify overarching categories and 
later assigned themes and sub-themes. This process was 
discussed with the study investigators (including a senior 
qualitative researcher) for refinement on a regular basis. 
Following the COM-B framework18 20 existing themes 
were used to interpret data and the framework was expanded 
adding 10 themes under capability, opportunity and motiva-
tion domains. At the later stage, one more domain titled 
“overall adherence element and health system factors” was 
added, which specifically focused on context-specific rea-
sons of non-adherence and health systems factors. This 
domain had two major themes on health care experience 
and trust in the facilities and reliance on alternative medica-
tion. Efforts were made to identify the association between 
themes until the “whole picture” emerged. Further patterns 
developed within the themes and concepts, and the original 
data were reflected constantly to ensure that participants’ 
views and perceptions were accurately presented.
Researchers constantly referred to reflexivity notes and 
field diary at the time of data analysis in order to make sense 
of language, symbols, and metaphors used by the respon-
dents. The researcher was also aware of her gender, age, 
affiliation while preparing the reflexivity notes. The research-
ers were also aware that the place of the interview might have 
shaped interview and interaction with the participant.
Findings
The analytical themes were derived from the COM-B 
framework (See Table 2).
Capability
The capability component helped in identifying the physi-
cal and psychological factors affecting the patients’ adher-
ence to medication.
Psychological Capability
Comprehension of Disease and Treatment
In the Indian context, participants reported varying degree 
of understanding about their condition, diagnostic tests and 
treatment, and only a few participants had 
a comprehensive understanding of these.
“I do not have much expertise and information, but the 
disproportionate cholesterol ratio increases the tendency of 
clotting. I want a solution for this cholesterol proportion 
and clotting”. (IND: Male: Age 63) 
In Ghana, some of the participants had not anticipated that 
they would develop CVD. Participants indicated that the 
onset of symptoms was often sudden and unexpected, 
resulting in hospitalisation.
“It was in January 2016 when I came to the hospital; I was 
feeling pain in my chest, so I came to the hospital … I did 
not know what it was and he (doctor) told me that I had 
developed heart disease, so he referred me to a doctor … ” 
(GHN: Female: Age 67) 
In both countries, female participants had limited informa-
tion about their condition as in many instances they relied on 
other family members to communicate with their doctors.
“I did not know anything. I did not even know if I was 
given an injection. I remember being shifted from one 
room to another … Later on, my children told me that 
the doctor had inserted something in my heart, but I could 
not get what it was.” (IND: Female: Age 51) 
Cognitive Functioning
This component helped in exploring patients’ health- 
seeking behaviour. In Ghana, most participants shared 
that they adhered to the treatment plan to cure their 
condition.
“It is my duty to remind myself. My wife also reminds me, 
but it is my duty. I know that by 8, I have to take the drug. 
Those that you will take the food before taking it is by me. 
When I finish, then I also take it but those that you take 
before taking the meal I take it.” [GHN, Male, 53 years] 
Some participants in India reported ignoring the primary 
symptoms of CVDs and delaying preventive treatment. 
They also discontinued their treatment after symptoms 
subsided.
“I stopped having the medicine from the current prescrip-
tion for diabetes and medicines which were prescribed 
earlier. So I shared it with the doctor, and they continued 
https://doi.org/10.2147/PPA.S285442                                                                                                                                                                                                                                  
DovePress                                                                                                                                               
Patient Preference and Adherence 2021:15 1362
Mishra et al                                                                                                                                                           Dovepress



































































the same (from the previous prescription) medication and 
also told me that the medication was suitable for my 
condition.” (IND: Female: Age 41) 
Executive Function
This refers to making and executing treatment plans. In 
both India and Ghana, some participants procured medi-
cines and planned their visits to the doctor well in 
advance.
“I decided to take drugs at night since I do not want to fall 
asleep during the day while I might be in town or doing 
something. When I take it at night, then I can sleep. But if 
I forget to take it at night then I will not feel sleepy, so 
quickly I will go for it and take it before I can sleep.” 
[GHN: Female: Age 37] 
Medicine and Daily Routine
Taking the medication on time also became a part of the 
daily routine for a few participants. For some participants, 
family played a vital role and reminded participants for 
their medication.
“The hypertension medication I was told to take early in 
the morning, so when I am done brushing my teeth, I take 
the medication first thing in the morning.”. (GHN: Female: 
Age 63) 
Medication Schedule
Participants shared that it was easy for them to adhere to 
medication because of fewer prescribed medicines. It was 
easy for them to remember and take all medicines at once.
Table 2 Major Analytical Themes and Sub-Themes: Expanding the *COM-B Framework




The individual’s physical 
and psychological capacity 
to engage in the behaviour 
Psychological 
Capacity to engage in the 
necessary thought process
● Comprehension of dis-
ease and treatment
● Cognitive functioning (eg 
memory, capacity for 
judgement, thinking)
● Executive function (eg 
capacity to plan)




Capacity to engage in the 
necessary physical 
process
● Physical capability to 
adapt to lifestyle changes 
(eg diet or social 
behaviour)
● Dexterity
● Unplanned Travel and 
Fatigue




● Perception of illness (eg cause, chronic vs acute 
etc.)
● Beliefs about treatment (eg necessity, efficacy, 
concerns about current or future adverse 
events, general aversion to taking medicines)
● Patients’ Perception of Health
● Outcome expectancies
● Fear of Recurrence of Event
● Self-efficacy
Automatic 
Emotions and impulses arising from associative 
learning and/or innate dispositions
● Stimuli or cues for action
● Mood state/disorder (eg depression and 
anxiety)
All factors lining outside the individual 
that makes the performance of the 
behaviour possible or prompt it 
Physical
● Cost
● Access (eg availability of medication)
● Health Insurance
● Availability of medication
● Packaging
● Physical characteristics of medicine 
(eg taste, smell, size, shape, route of 
administration)
● Regimen complexity
● Frequent Change in Medication
● Lack of Clarity in Prescription
● Social support
● HCP-patient relationship/ 
communication
● Limited Time for Consultation
Social 
The cultural milieu that dictates the 
way we think about things








● Reasons for 
adherence




● Health care experi-
ence and trust in 
the facilities
● Reliance on alterna-
tive medication
Notes: Adapted from Jackson C, Barber N, Eliasson L, Weinman J. Applying COM-B to medication 980adherence: a suggested framework for research and intervention. 
EurJ Health Psychol. 2014;16:7–17. Copyright (c) 2016 Christina Jackson,  Lina Eliasson, Nick Barber, John Weinman. This work is licensed under a Creative Commons 
Attribution 4.0 International License.18
Patient Preference and Adherence 2021:15                                                                                       https://doi.org/10.2147/PPA.S285442                                                                                                                                                                                                                       
DovePress                                                                                                                       
1363
Dovepress                                                                                                                                                           Mishra et al



































































“He (doctor) had advised me to have the medicine once in 
a day, so the night timing suits me well. I have food, and 
after that I have medicines.” (IND: Male: Age 40) 
Physical Capability
This refers to the individual’s physical ability to adhere to 
their treatment.
Unplanned Travel and Fatigue
Some factors contributing to non-adherence were similar 
across age groups and gender. Unexpected travel and 
physical fatigue were frequently cited reasons for non- 
adherence.
“I forget medicine only if I have to travel, and I leave 
home during day time and reach my destination at night 
and cannot get back home that day itself. I miss medicine 
only if I am not able to return home.” (IND: Male: Age 
48) 
Dexterity
In India, participants shared that they never sought help for 
medication, while in Ghana, participants reported waning 
ability to perform routine tasks, including medication. 
However, most participants had experienced a gradual 
improvement in their capacity to perform physical 
activities.
“First, I was able to wash clothes. I could go to the market 
and make a purchase, but I cannot do that right now. 
However, I have been told that it will get better. And 
when I get better, I will be able to do those things” 
(GHN: Female: Age 48) 
Opportunity
It is crucial to explore the available opportunities for 
patients in LMICs, which make them adhere to medica-




Participants told that due to the distantly located hospital 
pharmacy, they face various difficulties in accessing med-
icines. In addition, the unavailability of medicines of 
a particular brand was a challenge for many participants.
“it is very difficult to find this medicine named Embeta R, 
which was prescribed by the doctor [name] here. I did not 
find it anywhere. I spent around INR 1000-1100 for con-
veyance to search this medicine.” (IND: Male: Age 38) 
Cost of Medication
In India, some of the participants reported facing chal-
lenges in affording medication. For participants from 
both India and Ghana, the cost of medical procedures 
and medicines resulted in non-adherence and discontinued 
treatment.
“When I went to the hospital once again and asked the 
doctors to examine me, they advised that another stent will 
be inserted in my artery. Listening to that, I started crying 
in front of my Aunt and told her that this is beyond my 
{financial} capacity”. (IND: Male: Age 38) 
Health Insurance
In Ghana, the National Health Insurance Scheme was help-
ful for participants, who could not afford expensive medica-
tion; however, the insurance did not cover all the drugs.
“No, you can see, I have the insurance booklet. However, 
when I go to the dispensary, I am told that the drug is not 
covered. So the doctor gave me a prescription to go and 
buy (medicines from the market) because I could not get 
them at the dispensary.” (GHN: Female: Age 74) 
Availability of Medication
In India, subsidised medicines, available at the hospital 
pharmacy, facilitated adherence to medication among par-
ticipants. However, a few of them reported being unable to 
find some medicines at the hospital pharmacy prescribed 
by the doctor.
“Maybe because they are free and also generic medicines, 
so they are different in name since these generic medicines 
are less costly, that is why they are provided here (hospital 
pharmacy). This is what I think. This is the difference.” 
(IND: Male: Age 42)” 
In Ghana, there was a challenge with accessing drugs at 
the hospital pharmacy, where only a few medicines were 
covered under the National Health Insurance Scheme. 
Also, participants reported travelling from distant places 
and waiting for long hours to receive free medicines.
“When you come you will have to wait for a long time and 
spend all your time at the hospital” (GHN: Female: Age 
66) 
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Physical Characteristics and Packaging of the 
Medicines
Participants shared their experiences with medicines’ 
shape and size. It was difficult for some participants in 
India to swallow the capsules, while in Ghana, no partici-
pant reported any such issues.
“The only issue is that when I take a capsule or the tablet- 
like Rozucor or Prolomet R 25 mg, they do not go down 
my throat easily and stay there for long, even if I drink 
a lot of water.” (IND: Male: Age 68) 
However, different packaging or different trade names of 
prescribed drugs were problematic for some participants. 
They refused to take medicines with different brand 
names.
“I will tell them I do not like it, if they say it’s the same 
but different brand I do not like it, at times it might be fake 
so if you mix it with the drugs you are taking you might 
end up having some complications, or it will not work as 
expected, so I do not mix my drugs.” (GHN: Female: Age 
66) 
Regimen Complexity
Majority of the participants did not find their, medication 
regimen complex, and it was not a barrier to medication 
adherence. They complied with prescribed medications.
“No, it’s one pill daily, so that is why I take it only at night 
so I do not end up making it more than expected.” [GHN: 
Female: Age 37] 
Frequent Change in Medication
Frequent change in prescription adversely affected adher-
ence among participants. Change in medication was 
observed at three levels: change in the brand name; change 
in regimen; and change in medication due to delayed 
recovery. Consequently, the participants resorted to alter-
native medicines for immediate results.
“I told him that sometimes I feel weak. I start gasping if 
I walk fast. This is what I told him, and he kept on 
changing the medicine accordingly, and I have come this 
far, and now I am taking two medicines daily”. (IND: 
Male: Age 68) 
Healthcare Provider (HCP)-Patient Relationship/ 
Communication
Many participants cited Communication with their doctor 
as a challenge. They generally preferred to receive advice 
from their doctors and health workers who were not 
always forthcoming.
“I think he (doctor) should be able to tell us what lead to 
the condition and also what not to do and also not to 
overthink. I think this will help us because I think the 
doctor knows more than I do” (GHN: Female: Age 60 
years) 
Usually, at the health facilities in countries like India and 
Ghana, it is difficult for doctors to communicate with 
every patient in detail due to the disproportionate doctor- 
patient ratio.
“They (doctor) do not give us any information. When you 
go, they will just ask you how you are doing, and normally 
you do not always see one doctor. Always there is 
a different doctor to attend to you and all that they do is 
to look in the folder history and rewrite the former med-
ication for you. He will not explain anything to you, and 
all that he will do is to ask you to go and get the prescribed 
medication for you” (GHN: Female: Age 74 years) 
Lack of Clarity in Prescription
In India and Ghana, participants mentioned having pro-
blems understanding their prescriptions, and they relied on 
the pharmacist to provide information on their medication. 
However, in many instances, people working at the phar-
macy were not trained, pharmacists.
“We used to feel that this (OD, BD, BBF) is the name of 
the medicine. I used to think that OD means overdose. 
Yes, we can understand that zero (signifying number of 
doses) things, but we never got OD, HS, and BD etc. 
(IND: Male: Age 42) 
“Here, pharmacists do not converse with patients, but you 
can ask them questions if you have any complaints. And 
even some of the people at the drug store and pharmacy 
are not pharmacists” [GHN: Female: Age 66] 
Limited Time for Consultation
In India, the study was conducted at a tertiary care hospital, 
which provided specialised care to patients from all across 
the country. Due to low doctor-patient ratio, patients 
reported insufficient time for consultation with doctors.
“At this hospital, there were many patients. I went there 
once or twice if I had some problem. It used to be very 
suffocative during summer, and patients were huddled-up. 
Doctors did not have much time to give to the patients”. 
(IND: Male: Age 63) 
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Some participants got plenty of time with their doctor to 
discuss their health and related issues, while others faced 
challenges when doctors on duty were changed frequently. 
The other reason for the limited interaction between doc-
tors and patients was a lower doctor to patient ratio.
“The doctor has no time. Yeah. They will ask you, what is 
your problem, any complain? No complaint then they see 
the card and give you the drug.” [GHN: Male: Age, 59] 
Social Support
Words of encouragement, prayers and financial support 
from friends, church and community members were 
valued by patients and helped them in medication adher-
ence. Many participants shared that family members were 
very helpful in getting adequate treatment and in maintain-
ing a healthy lifestyle.
“That was a difficult time for me. My children used to feed 
me on the bed or the table I was doing everything on my 
own, and suddenly, one day, I was not able to do anything. 
I even required help to go to the toilet in the beginning.” 
(IND: Female: Age 56) 
Social Opportunity
Stigma of Disease
Stigma attached to the disease demotivated many partici-
pants in both countries and had an impact on medication 
adherence. In some cases, participants did not disclose 
their medical condition to their family. Some participants 
did exhibit self-pity and self-stigmatisation tendencies 
because of their ill condition.
“Actually when I got married, I had many problems as 
I was so scared of my stroke that I used to develop 
palpitation when I was with my in-laws. If I had to travel 
and I develop palpitation, I used to make excuses to use 
the washroom, and I would look for a chemist shop to buy 
Disprin to be at ease.” (IND: Female: Age 25) 
We observed some context-specific expressions of stigma. 
In India, some young women seemed to describe hiding 
their condition from their in-laws, which affected the sup-
port received and ultimately, their treatment adherence. In 
contrast, in Ghana, some men expressed their worries in 
being found out at work.
Religious and Cultural Belief
In Ghana, some participants cited their religious belief and 
acts of spirituality, including prayers as a means to cure 
their disease. They also believed witchcraft to be the cause 
of their suffering.
“A brother of mine told me that this thing does not happen 
on people by heart, but maybe somebody has done it to 
you so when you go in the spirit they can tell you the 
cause of your sickness, and that’s what I am expecting, 
I am very very serious, and it’s true too” (GHN: Male: 
Age 73) 
Motivation
Capability and opportunity have a direct impact on the 
motivation of a patient. Motivation is both reflective and 
automatic, which is shaped by personal experiences, per-
ception and social milieu.
Reflective
Perception of Illness
Participants varied in their perception of illness. Some 
Indian participants shared that they developed heart disease 
due to the family history of the disease and mental stress.
“Basically, if I have no worries and no stress in my life, 
smaller stress are fine, but greater stress is when you have 
no clue what to do then in that circumstance I face the 
problem. I face a lot of challenge in that situation.” (IND: 
Male: Age 63) 
Belief About Treatment
Participants in India showed trust in their treatment, and 
they attributed their recovery to their medication and 
treatment.
“I am getting treatment from the expert doctor. Therefore, 
I have no worries about that. I do not have to think if the 
doctor is already thinking about me. I have medicines 
without any worry.” (IND: Female: Age56) 
Some of them also shared concerns about the side effects 
of medicines. In Ghana, participants even resorted to tradi-
tional and alternative medicines as they felt that the med-
icine prescribed by their doctor did not bring significant 
improvement in their condition.
“You know it is said that when you take the drug in plenty, 
it will trouble you later, oh no people tell me that a lot, 
even my sister’s husband advice that I should take one 
because if I take them in plenty, it will give me side effect” 
(GHN: Female: Age 63) 
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Participants also shared that various health conditions like 
diabetes, urinary problems and hypertension led to medi-
cation non-adherence, as they were unaware of the effect 
of the medicines for ASCVD on other health-related con-
ditions that they had.
“Before then I have a urine-related problem that if I feel to 
urinate, then all of a sudden, the urine will come by itself 
and that exists still, and it still worries me.” (GHN: Male: 
Age 73) 
Patients’ Perception of Health
Some participants shared that they discontinued medica-
tion upon feeling that their health had improved. Opinions 
and advice from non-medical staff, especially friends and 
family, also led to non-adherence in some cases.
“I started feeling well, and did not face BP issue for quite 
some time, so I thought that there is no need to carry on 
with medicines anymore. Therefore, I stopped taking med-
icines.” (IND: Female: Age 51) 
Outcome Expectations
In conditions like ASCVD, patients have to take medica-
tion for an extended period. Participants from Ghana felt 
that the medicines were not effective, and recovery was 
delayed.
“Sometimes I expect that the changes should be more than 
it is now looking at the number of drugs I take but am not 
God and like I have been told by the lady that it is 
a gradual process, sometimes I feel dizzy, and my arm 
hurts and my legs too.” (GHN: Male: Age 63) 
Fear of Recurrence of Event
In some other cases, physical pain and the fear of recur-
rence motivated participants to adhere to medication.
“I am afraid of facing the bad times again, and I do not want 
to face that, I underwent so much of pain and agony, because 
of that fear I can even stop eating food but I always keep 
medicines with me. Even today, I have the stock of medi-
cines for coming six months.” (IND: Female: Age 47) 
Self-Efficacy
Most of the participants shared that they did not require 
any assistance in treatment and medication. In some cases, 
participants were altering the dose of medicines without 
consulting their doctor.
“No, the doctor had not told me to do so (alter the dose) 
I did that on my own. When I was going to [hospital], 
I had no other option, what would have I done. He had 
prescribed Atorva 20 mg to me, and I had to take 40 mg to 
compensate for a few missed doses.” (IND: Male: Age 48) 
Automatic
Stimuli or Cues for Action
The desire to live a long and a healthy life motivated many 
participants to adhere to medication, and they wanted to 
avoid the recurrence of an event that could be fatal.
“I had the information that skipping medication may lead 
to the recurrence of the attack. Therefore, I have not 
missed my medicine even for a day, and I always keep 
the extra stock of medicines. I am taking medicine in 
a disciplined manner”. (IND: Female: Age 56) 
Social support and family responsibility worked as an 
external stimulus for some participants to adhere to med-
ication. Some of them followed the advice of family 
members and friends for their medication.
“The Financial problem is always there. But my priority is 
not to stop the medication due to any reason because 
I want to live, and there be no one to take care of my 
wife and children … ” (IND: Male: Age 40) 
Mood
ASCVD affects the mental health and attitude of patients. 
Some participants reported developing mood swings and 
emotional instability, depression, fear of recurrence of 
stroke, and anger following the first event.
“Yes, there is one change that I have noticed, if there 
emerges any small or bigger issue at home or the work-
place, I get anxious. And as I feel anxious I feel numbness 
in my head, and then I want complete isolation, and I do 
not want anyone to talk to me, neither about good thing 
nor a bad thing … ” (IND: Male: 48) 
Overall Adherence Element and Health 
System Factors
Health Care Experience and Trust in the Facilities
In India, perception about the quality of care at the public 
sector hospital was quite positive among participants, as 
many of the participants had come to the government 
hospital after consulting doctors at various private 
hospitals.
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“I was satisfied that at least they (doctors) can diagnose 
my disease properly. They did not give any false hope and 
doing things properly. You feel good when you see that 
your doctors are connected to you, and they want to 
diagnose the disease adequately … ”. (IND: Female: Age 
25) 
In Ghana, most participants seemed to be dissatisfied with 
the services they received at the public health facility, as 
the doctors were not attentive and did not share informa-
tion related to diagnosis and treatment. They also com-
plained about drug shortage at the hospital’s pharmacy.
“For me, I have made up my mind to go to ridge hospital 
because the doctor who attends me is always going for 
inpatient wards rounds and she leaves the junior doctors 
around.” (GHN: Female: Age 68) 
Reliance on Alternative Medication
Some of the participants in Ghana shared that they relied 
on alternative and traditional medication, especially herbal 
medication. The few reasons given included the perceived 
lack of effectiveness of the allopathic medication and 
perceived effectiveness of herbal medicines and the side 
effects of the long-term treatment.
“My uncle is an herbalist, and he knows much about the 
herbs so after he saw the scan results, he told them that 
I had a stroke of the head. I was treated for five days with 
the herbal medicines and truly on the fourth day, I was 
able to move from one point to the other.” (GHN: Female: 
Age 35) 
In contrast, in India, some participants shared that Yoga 
and home remedies were beneficial for them, without the 
inconvenience of any side effects. However, these prac-
tices were complementary and did not have negative effect 
on participants’ adherence to their medication.
“I had even visited Patanjali (Ayurveda clinic). There also, 
doctors told me that you could take the Ayurvedic medi-
cine with the Allopathic medicines and there will not be 
any issue. These medicines are made of the barks and 
roots; thus, they will have no side effects. They instructed 
me to do Yoga.” (IND: Female: Age 56) 
Discussion
This qualitative study explored barriers and facilitators 
influencing medication adherence for ASCVD secondary 
prevention in two LMICs, India and Ghana. Adherence to 
medication, largely, was dependent on access, cost, 
physical and human characteristics of the health system, 
regimen complexity, and social support. We identified 
similarities in terms of barriers to medication in India 
and Ghana. The study manifests that the health system 
factors in LMICs played a vital role in limiting patient’s 
physical opportunity to adhere to medication.
Due to lack of information in both India and Ghana, 
many participants ignored primary symptoms, which 
resulted in delayed treatment and inadvertent non- 
adherence. Previous studies have also established the 
importance of health literacy and adequate information 
about medication influences adherence.20,21
A distantly located health facility was an access barrier. 
Also, in both countries, limited communication between 
the doctor and patient was a major reason for discontent 
among patients. Many other studies have highlighted that 
patients did not adhere to medication because they lack 
adequate information about it.22,23 Though patients in 
India did not report major difficulties with their medical 
regimen, some were unaware of the codes used in the 
prescription to indicate the medication’s timing. Thus, 
participants could not adhere to their prescription comple-
tely. In both countries, employees at the pharmacy 
explained medicines to the patients as medical language 
and clinical terms used in the prescription were beyond 
patients’ comprehension, but they were not trained phar-
macists. Medical vocabulary and clinical terms used in the 
prescription were beyond the comprehension of patients.
Financial constraints influencing adherence has been 
widely discussed in previous studies in LMICs.22–24 In 
this study, we found that some patients could not afford 
medication, which resulted in non-adherence. Lack of 
a well-stocked hospital pharmacy further aggravated pro-
blems for patients who could not afford costly medicines. 
Previous studies have also noted that irregular supply of 
better quality medicines at the pharmacy in the govern-
ment hospitals acts as an access barrier to medication, 
resulting in poor medication adherence.25 Therefore, in 
LMICs, there is also a need for an adequate drug procure-
ment system at the government hospitals to motivate 
patients to adhere to medication.
Unavailability of medicines with a particular brand 
name, as prescribed by the doctor, also resulted in non- 
adherence in India and Ghana. For many patients, 
unplanned travel, busy work schedules, and frequent 
changes in their prescription hindered medication compli-
ance. Participants in both countries also shared their con-
cerns about the side effects of long-term medication. 
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Another study exploring the barriers to medication adher-
ence among CVD patients noted that patients’ perception 
of the side effects of long-term medication prevented them 
from adhering to medication.22
Though in previous studies, the complexity of regimen 
was found to be associated with non-adherence,26 we did 
not find this to be the case for our participants. In both 
countries, patients with clear cognitive functioning were 
able to take a decision for their treatment and complied 
with prescribed medication. Invariably, for male and 
female participant, health literacy played an important 
role and affected adherence. In the case of female partici-
pants, the male counterpart in the family took major deci-
sions about their treatment. Most of the female participants 
were dependent on the male member of the family for 
medication and treatment. In both countries, participants 
who were self-dependent and took charge of their health 
and complied with medication. Other studies have also 
postulated that patients who can perform their daily activ-
ities independently and comfortably are mostly adherent to 
medication.23 Financial and emotional support from family 
members helped many participants in both countries 
adhere to medication. Many studies have underlined the 
family’s positive role in improving adherence.22,27 
Participants shared that their desire to live a healthy and 
long life made them adhere to medication. They also 
wanted to avoid recurrence of the cardiovascular event 
by complying with medication. Participants noted that 
medicines had become a part of their routine because 
they had been taking them for very long. Also, for a few 
participants, taking all the medicines together at 
a particular time was helpful in adhering to medication.
Though participants in India and Ghana shared various 
common factors, which hindered their medication adher-
ence, there were some barriers, which were specific to 
each of the settings. In Ghana, the government provided 
health insurance to patients, which facilitates patients‘me-
dication. Though some of the participants were covered 
under government health insurance scheme as either they 
were working or had retired from the government services, 
many Indian participants were not covered by any govern-
ment health insurance, which negatively impacted their 
medication adherence. However, since then government 
of India has launched Ayushman Bharat Pradhanmantri 
Jan Arogya Yojana in 2018, a flagship scheme programme 
to provide “health cover of Rs. 5 lakhs per family per year 
for secondary and tertiary care hospitalization to over 
10.74 crores poor and vulnerable families”.28
Additionally, in the Indian context, many participants 
could not share their medical condition with family 
because of social stigma attached to the disease, which 
influenced their medication negatively. Whereas in Ghana, 
reliance on alternative medication resulted in non- 
adherence among participants. There are various reasons 
for reliance on alternative medication, including easy 
availability, inexpensive medication, and trust in the effi-
cacy of the alternative medication. The religious and cul-
tural belief was very strong among participants in Ghana; 
in some cases, participants relied on prayers and did not 
adhere to medication after they were discharged from the 
hospital. The barriers to medication adherence identified in 
this study are broadly similar to the barriers in other 
settings. However, reliance on alternative medicines and 
lack of faith in modern medication was specific to Ghana. 
The participants, who could not understand their prescrip-
tion, tend to miss medication or fail to adhere to their 
treatment, resulting in slow recovery or recurrence of the 
event. This had a significant impact on the patients’ belief 
system, and they develop doubts about the treatment they 
were receiving.
This study has highlighted that the health system fac-
tors have dominantly influenced adherence to medication 
in India and Ghana. In both the countries, we found 
participants to be satisfied with their health care provided 
at the government hospitals, but limited time for consulta-
tion, lack of well-stocked pharmacy and unclear prescrip-
tion negatively influenced adherence among participants. 
The study emphasises that the health system needs to be 
strengthened, and the patient’s belief system needs to 
explore to address the issue of medication adherence in 
LMICs.
Strengths and Limitations
This study will help develop psychological understanding 
of patients’ health-seeking behaviour and their complex 
interaction with the health systems component in LMICs. 
The previous frameworks18,29 have focused on human and 
health systems elements. In this study efforts have been 
made to explore contextual factors associated with health 
systems and patients‘ belief systems such as reliance on 
alternative medication, lack of clarity in prescription, and 
perception about public and private hospital. We came 
across these factors common in both India and Ghana 
while exploring barriers and facilitators using the COM- 
B framework. These factors have customary/social, psy-
chological and systemic roots in LMICs.
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While the identified barriers and facilitators were consis-
tent in both countries, we also acknowledge that the study 
was confined to a single health facility in each country. We 
also recognise that the study was conducted at the tertiary 
referral hospitals and explored the barriers and facilitators 
beyond that could have helped develop a broader perspec-
tive. However, we made sure that we reached thematic 
saturation in both countries. Also, due to fewer female parti-
cipants in the study, we could have missed specific barriers 
related to the challenges women face in accessing health 
care. The other limitation with this study -low number of 
subjects, however, we ensured that there is an adequate 
representation of men and women, different age groups and 
educational and socio-economic backgrounds and data 
saturation. There is a need to explore the barriers using 
a gender lens to make a holistic and robust theoretical back-
ground for medication adherence intervention.
Our study was conducted with a focus to generate 
a cumulative evidence base not only for policymaking 
but also to raise questions about local barriers and facil-
itators for further research. The study can inform health 
policymaking in LMICS where ASCVD is contributing to 
a huge number of deaths due to various socio-economic, 
psychological and systemic factors.
Conclusion
We have used the COM-B framework to explore contextual 
and health systems factors in LMICs influencing patients’ 
adherence. Strict and comprehensive medication compliance 
was a challenge for both adherent and non-adherent partici-
pants across the gender and age group. The study highlights 
the importance of sharing patients’ experience to design 
behaviour change interventions addressed to their specific 
problems to help them comply with their medication.
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